Perseus Proteomics Inc. (TYO:4882)
Japan · Delayed Price · Currency is JPY 255.00
+1.00 (0.39%)
Jan 22, 2026, 3:30 PM JST
Perseus Proteomics Market Cap
Perseus Proteomics has a market cap or net worth of 3.75 billion as of January 22, 2026. Its market cap has decreased by -55.41% in one year.
Market Cap
3.75B
Enterprise Value
2.36B
Revenue
121.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
255.00
Market Cap Chart
Since June 22, 2021, Perseus Proteomics's market cap has decreased from 10.12B to 3.75B, a decrease of -62.98%. That is a compound annual growth rate of -19.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 3.76B | 13.84% |
| Dec 30, 2025 | 3.30B | -60.12% |
| Dec 30, 2024 | 8.28B | 13.70% |
| Dec 29, 2023 | 7.29B | 97.33% |
| Dec 30, 2022 | 3.69B | -20.91% |
| Dec 30, 2021 | 4.67B | -53.87% |
| Jun 22, 2021 | 10.12B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 13.54T |
| HOYA Corporation | 8.53T |
| Takeda Pharmaceutical Company | 8.01T |
| Daiichi Sankyo Company | 6.05T |
| Otsuka Holdings | 4.69T |
| Astellas Pharma | 3.99T |
| Terumo | 3.25T |
| Shionogi & | 2.42T |